ZOLOFT is a prescription medicine used to treat depression, panic disorder, obsessive-compulsive disorder (also called OCD) and posttraumatic stressdisorder (also called PTSD) in adults.
ZOLOFT is also used to treat OCD in children (ages 6-12) and adolescents (ages 12-17).
|zoloft 25mg pills|
|zoloft 25mg × 30 pills||price $72.00||per pill 2.40|
|zoloft 25mg × 60 pills||price $88.20||per pill 1.47|
|zoloft 25mg × 90 pills||price $104.40||per pill 1.16|
|zoloft 50mg pills|
|zoloft 50mg × 30 pills||price $75.90||per pill 2.53|
|zoloft 50mg × 60 pills||price $93.00||per pill 1.55|
|zoloft 50mg × 90 pills||price $109.80||per pill 1.22|
|zoloft 50mg × 180 pills||price $158.40||per pill 0.88|
|zoloft 100mg pills|
|zoloft 100mg × 30 pills||price $99.00||per pill 3.30|
|zoloft 100mg × 60 pills||price $120.00||per pill 2.00|
|zoloft 100mg × 90 pills||price $140.40||per pill 1.56|
|zoloft 100mg × 180 pills||price $199.80||per pill 1.11|
ZOLOFT is supplied for oral administration as scored tablets containing sertraline hydrochloride equivalent to 25, 50 and 100 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, D & C Yellow #10 aluminum lake (in 25 mg tablet), FD & C Blue #1 aluminum lake (in 25 mg tablet), FD & C Red #40 aluminum lake (in 25 mg tablet), FD & C Blue #2 aluminum lake (in 50 mg tablet), hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, synthetic yellow iron oxide (in 100 mg tablet), and titanium dioxide.
ZOLOFT oral concentrate is available in a multidose 60 mL bottle. Each mL of solution contains sertraline hydrochloride equivalent to 20 mg of sertraline. The solution contains the following inactive ingredients: glycerin, alcohol (12%), menthol, butylated hydroxytoluene (BHT). The oral concentrate must be diluted prior to administration.
Researchers have created a smartphone app - called Phenomizer - that scans thousands of characteristics of hereditary diseases to present doctors with the most likely diagnosis.
The spread of deadly Ebola virus in West Africa shows no sign of slowing down prompting fears that it will spread to other continents.
Johns Hopkins researchers have achieved 70% accuracy with a new blood and saliva test for predicting recurrence of HPV-related cancers. However, further refinements are needed.